New Zealand markets closed

West Pharmaceutical Services, Inc. (WST)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
331.80-4.49 (-1.34%)
As of 03:07PM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 24.50B
Enterprise value 24.20B
Trailing P/E 44.37
Forward P/E 44.84
PEG ratio (5-yr expected) 6.06
Price/sales (ttm)8.61
Price/book (mrq)9.14
Enterprise value/revenue 8.26
Enterprise value/EBITDA 29.61

Trading information

Stock price history

Beta (5Y monthly) 1.01
52-week change 3-7.11%
S&P500 52-week change 323.23%
52-week high 3415.73
52-week low 3310.42
50-day moving average 3356.08
200-day moving average 3364.27

Share statistics

Avg vol (3-month) 3480.32k
Avg vol (10-day) 3549.97k
Shares outstanding 572.84M
Implied shares outstanding 673.21M
Float 872.35M
% held by insiders 10.57%
% held by institutions 196.08%
Shares short (15 May 2024) 41.14M
Short ratio (15 May 2024) 42.14
Short % of float (15 May 2024) 42.05%
Short % of shares outstanding (15 May 2024) 41.56%
Shares short (prior month 15 Apr 2024) 4975.86k

Dividends & splits

Forward annual dividend rate 40.8
Forward annual dividend yield 40.24%
Trailing annual dividend rate 30.78
Trailing annual dividend yield 30.23%
5-year average dividend yield 40.26
Payout ratio 410.29%
Dividend date 307 Aug 2024
Ex-dividend date 431 Jul 2024
Last split factor 22:1
Last split date 327 Sept 2013

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024


Profit margin 19.42%
Operating margin (ttm)18.06%

Management effectiveness

Return on assets (ttm)11.40%
Return on equity (ttm)20.84%

Income statement

Revenue (ttm)2.93B
Revenue per share (ttm)39.55
Quarterly revenue growth (yoy)-3.00%
Gross profit (ttm)N/A
Net income avi to common (ttm)568.7M
Diluted EPS (ttm)7.57
Quarterly earnings growth (yoy)-17.60%

Balance sheet

Total cash (mrq)601.8M
Total cash per share (mrq)8.26
Total debt (mrq)306.6M
Total debt/equity (mrq)11.44%
Current ratio (mrq)2.61
Book value per share (mrq)36.72

Cash flow statement

Operating cash flow (ttm)756.6M
Levered free cash flow (ttm)143.34M